Unlocking the potential of N-myristoyltransferase (NMT) to develop precision medicines for a range of diseases including cancer and viral infections
Delivering groundbreaking therapies for autoimmune diseases & cancer.
George Medicines is an innovative late-stage drug development company focused on the large, expanding and underserved market for the management of non-communicable diseases (NCDs)
High Quality Serum for Biochemistry Analysis: A proprietary blood collection tube rapidly providing high quality serum for analysis from all bloods including anti-coagulated.
Ena Respiratory is a biotechnology company aiming to transform the treatment and prevention of respiratory infections. The company initial focus is to target respiratory infections in patients with asthma and COPD.
Osprey Medical’s DyeVert™ Plus System reduces contrast media in order to make angiography safer for Chronic Kidney Disease (CKD) patients.
Developing antibiotic therapy for cystic fibrosis
Developing innovative DNA sequencing technology
Developing vaccines that target the major virulence factors produced by the bacterium Porphyromonas gingivalis (P gingivalis)
PolyActiva is a clinical-stage biotechnology company focussed on the development of ocular implants.
Certa Therapeutics novel drugs block a receptor that is a key driver of fibrosis (scarring) of the kidney and other organs. Certa is able to use genetic analysis to identify those patients that are most likely to benefit from therapy.
